House Reps. Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.), co-sponsors of the Alzheimer’s Screening and Prevention (ASAP) Act, said Thursday that proactively addressing Alzheimer’s disease is “too expensive” of an issue for Congress to ignore.

Appearing on Thursday at The Hill’s “Getting a Diagnosis ASAP: Progress in Early Alzheimer’s Detection” event, sponsored by the Alliance for Aging Research, the two congressmen discussed why their bill, the ASAP Act, is crucial.

Read it HERE